Abstract
Adenoviruses (Ad) are important pathogens in a variety of species. In humans, Ad are most commonly recognized in the respiratory tract and conjunctiva. However, several members of this large family of viruses can cause disease in the gastrointestinal tract, while others infect the urinary tract, liver, and central nervous system (Horwitz 1990b). In dogs, a canine Ad is a major cause of hepatitis, and the murine adenovirus type 1 (MAV-1) can cause multiorgan disease in the mouse (Ishibashi and Yasue 1984). However, the Ad that infect each species are sufficiently different that they do not cross into distantly related species. For example, human Ad replicate poorly in mice or murine tissue culture. There are 49 distinct serotypes that can infect humans, but the majority of Ad disease is caused by approximately one third of this number (Schnurr and Dondero 1993; Hierholzer et al. 1988). Ad are classified into six groups (A-F) based on GC content and genetic relatedness of their DNA, oncogenicity in rodents, and ability to agglutinate red blood cells of different species (Horwitz 1990a). The organ targeted for disease is often related to serotype, such that Ad7 causes pneumonia, Ad2 upper respiratory tract disease, Ad40 and Ad41 cause diarrhea, Ad11 is associated with hemorrhagic cystitis, and Ad34 and Ad35 are often found in the urinary tract of immunosuppressed patients (Horwitz 1990b). However, the reason for tissue-specific damage in relationship to serotype is unknown.
Keywords
- Major Histocompatibility Complex
- Tumor Necrosis Factor Alpha
- Vaccinia Virus
- Newcastle Disease Virus
- Adenovirus Type
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Aderka D, Novick D, Hahn T, Fischer DG, Wallach D (1985) Increase of vulnerability to lymphotoxin in cells infected by vesicular stomatitis virus and its further augmentation by interferon. Cell Immunol 92:218–225
Arroyo M, Bagchi S, Raychaudhuri P (1993) Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex. Mol Cell Biol 13: 6537–6546
Ball AO, Williams ME, Spindler KR (1988) Identification of mouse adenovirus type 1 early region 1: DNA sequence and a conserved transacting function. J Virol 62: 3947–3957
Binder D, Kündig TM (1991) Antiviral protection by CD8+ versus CD4+ T cells. J Immunol 146:4301–4307
Blanden RV (1970) Mechanisms of recovery from a generalized viral infection: mousepox. J Exp Med 132:1035–1054
Blanden RV (1971) Mechanisms of recovery from a generalized viral infection: mousepox. J Exp Med 133:1074–1089
Chen M, Mermod N, Horwitz MS (1990) Protein-protein interactions between adenovirus DNA polymerase and nuclear factor I mediate formation of the DNA replication preinitiation complexes. J Biol Chem 265: 18634–18642
Cotten M, Wagner E, Zatloukal K, Birnstiel ML (1993) Chicken adenovirus (CELO virus) particles augment receptor-mediated DNA delivery to mammalian cells and yield exceptional levels of stable transformants. J Virol 67: 3777–3785
Cox JH, Yewdell JW, Eisenlohr LC, Johnson PR, Bennink JR (1990) Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Science 247: 715–718
Debbas M, White E (1993) Wild-type p53 mediates apoptosis by E1 A, which is inhibited by E1B. Genes Dev 7: 546–554
Faha B, Harlow E, Lees E (1993) The adenovirus E1A-associated kinase consists of cyclin E-p33cdk2 and cyclin A-p33cdk2. J Virol 67: 2456–2465
Fejer G, Gyory I, Tufariello J, Horwitz MS (1994) Characterization of transgenic mice containing adenovirus early region 3 genomic DNA J Virol 68: 5871–5881
Flomenberg PR, Chen M, Horwitz MS (1987) Characterization of a major histocompatibility complex class I antigen-binding glycoprotein from adenovirus type 35, a type associated with immunocompromised hosts. J Virol 61: 3665–3671
Ginsberg HS, Dingle JH (1965) The adenovirus group. Horsfall FL Jr, Tamm I (Eds) Viral and rickettsial infections of man. Lippincott, Philadelphia, pp 860–891
Ginsberg HS, Lundholm-Beauchamp U, Horswood RL, Pernis B, Wold WSM, Chanock RM, Prince GA (1989) Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc Natl Acad Sci USA 86: 3823–3827
Ginsberg HS, Horswood RL, Chanock RM, Prince GA (1990) Role of early genes in pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci U S A 87: 6191–6195
Ginsberg HS, Moldawer LL, Sehgal PB, Redington M, Kilian PL, Chanock RM, Prince GA (1991) A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci USA 88: 1651–1655
Gooding LR, Elmore LW, Tollefson AE, Brady HA, Wold WSM (1988) A 14 700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell 53: 341–346
Gooding LR, Ranheim TS, Tollefson AE, Aquino L, Duerksen-Hughes PJ, Horton TM, Wold WSM (1991) The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor. J Virol 65(8): 4114–4123
Greber UF, Willetts M, Webster P, Helenius A (1993) Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75: 477–486
Grunhaus A, Horwitz MS (1992) Adenoviruses as cloning vectors. Rice C (ed) Seminars in virology Saunders Scientific, London, pp 237–252
Grunhaus A, Cho S, Horwitz MS (1994) Association of vaccinia virus-expressed adenovirus E3-19K glycoprotein with class I MHC and its effects on virulence in a murine pneumonia model. Virology 200:535–546
Hay-Ahmad Y, Graham FL (1986) Development of a helper-independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene. J Virol 57: 267–274
Hierholzer JC, Wigand R, Anderson LJ, Adrian T, Gold JWM (1988) Adenovirus from patients with AIDS: a plethora of serotypes and a description of five new serotypes of subgenus D (types 43–47) J Infect Dis 158: 804–813
Hirsch MS, Nahmias AJ, Murphy FA, Kramer JH (1968) Cellular immunity in vaccinia infection of mice. J Exp Med 128: 121–132
Horton TM, Ranheim TS, Aquino L, Kusher DI, Saha SK, Ware CF, Wold WSM, Gooding LR (1991) Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis. J Virol 65(5): 2629–2639
Horwitz MS (1990a) Adenoviridae and their replication. Fields BN, Knipe DM, Chanock RM, Melnick JL, Hirsch MS, Monath TP, Roizman B (eds) Virology, 2nd edn. Raven, New York, pp 1679–1721
Horwitz MS (1990b) Adenoviruses. Fields BN, Knipe DM, Chanock RM, Melnick JL, Hirsch MS, Monath TP, Roizman B (eds) Virology, 2nd edn. Raven, New York, pp 1723–1740
Horvath J, Palkonyay L, Weber J (1986) Group C adenovirus DNA sequences in human lymphoid cell. J Virol 59: 189–192
Ikeda MA, Nevins JR (1993) Identification of distinct roles for separate E1A domains in disruption of E2F complexes. Mol Cell Biol 13: 7029–7035
Ishibashi M, Yasue H (1984) Adenoviruses of animals. Ginsberg HS (ed) The adenoviruses. Plenum, New York, pp 497–562
Klessig DF, Quinlan MP (1982) Genetic evidence for separate functional domains of the human adenovirus specified, 72K, DNA-binding protein. J Mol Appl Genet 1: 263–272
Koff WC, Fann AV (1986) Human tumor necrosis factor-α kills herpesvirus-infected but not normal cells. Lymphokine Res 5: 215–221
Korner H, Fritzsche U, Burgert HG (1992) Tumor necrosis factor a stimulates expression of adenovirus early region 3 proteins: implications for viral persistence. Proc Natl Acad Sci U S A 89:11857–11861
Krajcsi P, Tollefson AE, Wold WSM (1992) The E3-14.5K integral membrane protein of adenovirus that is required for down-regulation of the EGF receptor and for prevention of TNF cytolysis is O-glycosylated but not N-glycosylated. Virology 188: 570–579
Kraus VB, Moran E, Nevins JR (1992) Promoter-specific trans-activation by the adenovirus E1A 12S product involves separate E1A domains. Mol Cell Biol 12: 4391–4399
Lavery DJ, Fu SM, Lufkin T, Chen-Kiang S (1987) Productive infection by cultured human lymphoid cells by adenovirus. J Virol 61: 1466–1472
Lonberg-Holm K, Crowell RL, Philipson L (1976) Unrelated animal viruses share receptors. Nature 259: 678–681
Lorence RM, Rood PA, Kelly KW (1988) Newcastle disease virus as an antineoplastic agent: induction of tumor necrosis factor-α and augmentation of its cytotoxicity. J Natl Cancer Inst 80: 1305–1312
Lowe SW, Ruley HE (1993) Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev 7: 535–545
Ma Y, Mathews MB (1993) Comparative analysis of the structure and function of adenovirus virus-associated RNAs. J Virol 67: 6605–6616
Michael SI, Huang CH, Romer MU, Wagner E, Hu PC, Curiel DT (1993) Binding-incompetent adenovirus facilitates molecular conjugate-mediated gene transfer by the receptor-mediated endocytosis pathway. J Biol Chem 268: 6866–6869
Mittal SK, McDermott MR, Johnson DC, Prevec L, Graham FL (1993) Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Res 28: 67–90
Otten JA, Tennant RW (1982) The mouse in biomedical research, 2nd edn. Academic, New York pp 335–340
Prince GA, Porter DD, Bennett Jenson A, Horswood RL, Chanock RM, Ginsberg HS (1993a) Pathogenesis of adenovirus type 5 pneumonia in cotton rats. J Virol 67: 101–111
Prince GA, Porter DD, Jenson AB, Horswood RL, Chanock RM, Ginsberg HS (1993b). Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus). J Virol 67: 101–111
Ragot T, Vincent N, Chafey P, Vigne E, Gilgenkrantz H, Couton D, Cartaud J, Briand P, Kaplan J-C, Perricaudet M, Kahn A (1993) Efficient adenovirus-mediated transfer of a human minidystroph in gene to skeletal muscle of mdx mice. Nature 361: 647–650
Rao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S, White E (1992) The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc Natl Acad Sci USA 89: 7742–7746
Raviprakash KS, Grunhaus A, Elkholy A, Horwitz MS (1989) The mouse adenovirus type 1 contains an unusual E3 region. J Virol 63: 5455–5458
Rowe WP, Huebiner RJ, Gillmore LK, Parrott RH, Ward TG, (1953) Isolation of a cytogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med 84: 570–573
Sambhi SK, Kohonen-Corish MRJ, Ramshaw IA (1991) Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo. Proc Natl Acad Sci USA 88: 4025–4029
Schnurr D, Dondero ME (1993) Two new candidate adenovirus serotypes. Intervirology 36: 79–83
Smith AL, Barthold SW (1987) Factors influencing susceptibility of laboratory rodents to infection with mouse adenovirus strains K 87 and FL. Arch Virol 95: 143–148
Spriggs MK, Koller BH, Sato T, Morrisey PJ, Fanslow WC, Smithies O, Voice RF, Widmer MB, Maliszewski CR (1992) β2-Microglobulin, CD8+T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc Natl Acad Sci USA 89: 6070–6074
Tufariello J, Cho S, Horwitz MS (1994a) The adenovirus E3 14.7-kilodalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model. J Virol 68: 453–462
Tufariello J, Cho S, Horwitz MS (1994b) Adenovirus E3 14.7K protein, an antagonist of tumor necrosis factor cytolysis, increases the virulence of vaccinia virus in severe combined immunodeficient mice. Proc Natl Acad Sci USA 91: 10987–10991
Wagner E, Zatloukal K, Cotten M, Kirlappos H, Mechtler K, Curiel DT, Bimstiel ML (1992) Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci USA 89: 6099–6103
Wickham TJ, Mathias P, Cheresh DA, Nemerow GR (1993) Integrins αvβ3S and αvβ5 promote adeno virus internalization but not virus attachment. Cell 73: 309–319
Wold WSM, Gooding LR (1991) Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 184: 1–8
Wold WSM (1995) E3 transcription unit of adenovirus. In: Doerfler W, Böhm P (eds) The molecular repertoire of adenoviruses. Springer, Berlin, Heidelberg New York (current topic’s in microbiology and immunology, vol 199/I): 237–274
Wong GHW, Goeddel DV (1986) Tumor necrosis factors a and ß inhibit virus replication and synergize with interferons. Nature 323: 819–822
Zabner J, Couture LA, Gregory RJ, Graham SM, Smith AE, Welsh MJ (1993) Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75: 207–216
Zilli D, Voelkel-Johnson C, Skinner T, Laster SM (1992) The adenovirus E3 region 14.7 kDa protein, heat and sodium arsinate inhibit the TNF-induced release of arachidonic acid. Biochem Biophys Res Commun 188(1): 177–183
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Horwitz, M.S., Tufariello, J., Grunhaus, A., Fejer, G. (1995). Model Systems for Studying the Effects of Adenovirus E3 Genes on Virulence In Vivo. In: Doerfler, W., Böhm, P. (eds) The Molecular Repertoire of Adenoviruses III. Current Topics in Microbiology and Immunology, vol 199/3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79586-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-79586-2_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79588-6
Online ISBN: 978-3-642-79586-2
eBook Packages: Springer Book Archive